Breast Cancer Clinical Trial
Mindful Movement Program in Improving Quality of Life in Older Female Breast Cancer Survivors
Summary
RATIONALE: Mindful movement is a self-directed activity of mindfulness (intention, attention, and attitude) and physical movement. A mindful movement program may be effective in improving well-being in older women who are breast cancer survivors.
PURPOSE: This randomized clinical trial is studying how well a mindful movement program works in improving quality of life in older female breast cancer survivors.
Full Description
OBJECTIVES:
To test the effects of the 12-week Mindful Movement Program on quality of life in older female breast cancer survivors.
To test the effects of this program on mindfulness outcomes in these participants.
To compare mindfulness qualities in the experimental group with the control group.
To determine the qualitative benefits of this program as described by these participants.
OUTLINE: Participants are randomized to 1 of 2 intervention arms.
Arm I (Mindful Movement Program [MMP]): Participants undergo a 2-hour MMP session once weekly for 12 weeks. Participants are encouraged to practice intentional-mindful movement at home 5 minutes daily during weeks 1-4, 10 minutes daily during weeks 5-8, and 15 minutes daily during weeks 9-12. Mindful movement is a self-directed activity incorporating mindfulness concepts and physical movement. Mindfulness consists of the three core elements: intention (reasons for participating in a mindfulness intervention), attention (observing experiences in the present moment), and attitude (nonjudgmental openness and acceptance of experiences). Each MMP session includes verbal sharing with a partner and the group and movement individually and with a partner, while focusing on the elements of mindfulness. Music is incorporated into some portion of each session.
Arm II (control): Participants undergo no intervention. All participants complete questionnaires for sociodemographic and individual characteristics, quality of life (including psychological, social, spiritual, and physical well-being, anxiety and depression, fear of recurrence, body image, and upper body symptoms), movement, and mindfulness (including attention, self-compassion, and intention) at baseline and weeks 12 and 18.
PROJECTED ACCRUAL: A total of 75 participants (45 in the experimental group and 30 in the control group) will be accrued for this study.
Eligibility Criteria
DISEASE CHARACTERISTICS:
Breast cancer survivor
At least 12 months since completion of treatment (chemotherapy, biotherapy [e.g., trastuzumab], or radiotherapy)
No evidence of metastatic disease
PATIENT CHARACTERISTICS:
English speaking
Not under acute psychological distress
Not using an assistive device (cane, walker, or wheelchair)
Able to participate in the Mindful Movement Program by a medical release from the patient's physician
Pregnancy allowed
PRIOR CONCURRENT THERAPY:
See Disease Characteristics
Concurrent selective estrogen-receptor modulator permitted
No other concurrent treatment
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Duarte California, 91010, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.